InVivo Therapeutics Holdings Corp. (NVIV) Gained 7.69% or 0.06 To Price $0.77 On Thursday


InVivo Therapeutics Holdings Corp. (NVIV) gained 7.69% or 0.06 to $0.77. It is nearly 226537 shares traded, which is 76.45% compare to the average total volume 296303. The market cap of NVIV is $26.36 million. The year to date change is -21.43%. The 52 week price range is from $0.6 to $4.95. Price of NVIV have changed -5.92% during last week. It have changed -35.00% over last month, -60.28% over last 3 months, -71.96% over last 6 months and -82.77% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVIV is 1.15. It is 49.35% above current price. The 200-day Moving Averages for NVIV is 2.05. It is 166.23% above current price. The 52-week High is 4.95. It is 542.86% from the current price. The 52-week Low is 0.6. It is -22.08% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NVIV is 5.65 on 2017-12-15. Short % to float is 6.66%. There are some statistics of NVIV. It is has market cap $26.36 million. The share outstanding is 34.24 million. The average volume is 296303. The percent of top 15 Institution holding is 11.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVIV is -116.86%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVIV is -94.76%.


Tags:

Share this post